Jacob Alderete
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jacob Alderete has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Abhinav Suri
Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, Calif
2 shared publications - Andrew C. Vivas
Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, USA
2 shared publications - Anshul Ratnaparkhi
Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA
2 shared publications - Bayard Wilson
Department of Neurosurgery, University of California, Los Angeles, Los Angeles, California, USA
2 shared publications - David A. Zarrin
David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
2 shared publications - David Berin
Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
2 shared publications
Latest Publications
- 13 April 2026
- Published by Wolters Kluwer Health in Neurosurgery
Choroid Plexus Cauterization Prevents Postoperative Hydrocephalus in Adult Glioblastoma Resection With Ventricular Entry
BACKGROUND AND OBJECTIVES: Glioblastoma often extends along the subventricular zone and resection frequently results in ventricular entry, which is associated with increased risk of postoperative hydrocephalus. Choroid plexus cauterization (CPC) is a treatment for pediatric hydrocephalus, but its utility in preventing postoperative hydrocephalus following glioblastoma resection with ventricular entry is unknown. We sought to characterize CPC safety and efficacy in preventing postoperative hydrocephalus in this setting. METHODS: We evaluated a historical cohort of 260 patients who underwent craniotomy for glioblastoma with ventricular entry, assessing postoperative hydrocephalus, survival, and functional outcomes. Furthermore, we prospectively performed CPC in a matched cohort with ventricular entry. We quantitated the volume of choroid plexus that was successfully cauterized using magnetic resonance segmentation and evaluated the safety and efficacy of CPC. RESULTS: 25.8% of patients with glioblastoma resection with ventricular entry developed postoperative hydrocephalus. Hydrocephalus was associated with more readmissions (2.3 vs 0.6; P < .0001), longer hospital stays (10.0 vs 6.5 days; P = .0047), and lower 3-month Karnofsky Performance Status (64.4 vs 78.6; P < .0001), although overall survival was unaffected. Thirty patients underwent prospective CPC with no procedure-related postoperative complications. Choroid plexus volume in the involved ventricle decreased by 50% on postoperative MRI segmentations ( P = .0020). In a matched analysis, there was a reduction in postoperative hydrocephalus compared with the retrospective cohort (3.3% vs 25.8%; P = .0060) associated with fewer hospital readmissions ( P = .0330). CONCLUSION: As ventricular entry becomes increasingly common during supramaximal glioblastoma resection, our data demonstrate that patients who develop postoperative hydrocephalus have more readmissions, longer hospital stays, and worse functional status. Thus, strategies to reduce postoperative hydrocephalus are critical. Although it does not alter the natural course of glioblastoma itself, we find that CPC represents a safe and effective adjunct that prevents postoperative hydrocephalus, reduces hospital readmissions, and downstream interventions, which is extremely important to a patient cohort with limited expected survival.
- 13 April 2026
- Published by Wolters Kluwer Health in Neurosurgery
Choroid Plexus Cauterization Prevents Postoperative Hydrocephalus in Adult Glioblastoma Resection With Ventricular Entry
BACKGROUND AND OBJECTIVES: Glioblastoma often extends along the subventricular zone and resection frequently results in ventricular entry, which is associated with increased risk of postoperative hydrocephalus. Choroid plexus cauterization (CPC) is a treatment for pediatric hydrocephalus, but its utility in preventing postoperative hydrocephalus following glioblastoma resection with ventricular entry is unknown. We sought to characterize CPC safety and efficacy in preventing postoperative hydrocephalus in this setting. METHODS: We evaluated a historical cohort of 260 patients who underwent craniotomy for glioblastoma with ventricular entry, assessing postoperative hydrocephalus, survival, and functional outcomes. Furthermore, we prospectively performed CPC in a matched cohort with ventricular entry. We quantitated the volume of choroid plexus that was successfully cauterized using magnetic resonance segmentation and evaluated the safety and efficacy of CPC. RESULTS: 25.8% of patients with glioblastoma resection with ventricular entry developed postoperative hydrocephalus. Hydrocephalus was associated with more readmissions (2.3 vs 0.6; P < .0001), longer hospital stays (10.0 vs 6.5 days; P = .0047), and lower 3-month Karnofsky Performance Status (64.4 vs 78.6; P < .0001), although overall survival was unaffected. Thirty patients underwent prospective CPC with no procedure-related postoperative complications. Choroid plexus volume in the involved ventricle decreased by 50% on postoperative MRI segmentations ( P = .0020). In a matched analysis, there was a reduction in postoperative hydrocephalus compared with the retrospective cohort (3.3% vs 25.8%; P = .0060) associated with fewer hospital readmissions ( P = .0330). CONCLUSION: As ventricular entry becomes increasingly common during supramaximal glioblastoma resection, our data demonstrate that patients who develop postoperative hydrocephalus have more readmissions, longer hospital stays, and worse functional status. Thus, strategies to reduce postoperative hydrocephalus are critical. Although it does not alter the natural course of glioblastoma itself, we find that CPC represents a safe and effective adjunct that prevents postoperative hydrocephalus, reduces hospital readmissions, and downstream interventions, which is extremely important to a patient cohort with limited expected survival.
- Open Access
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4, e72535
The Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians
Background: Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. Objective: This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. Methods: The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. Results: Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. Conclusions: To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine.
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4, e72535
Open AccessThe Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians
Background: Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. Objective: This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. Methods: The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. Results: Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. Conclusions: To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine.
- 25 June 2025
- Published by Elsevier in The Journal of Pain
- Vol. 35, 105474
Opposing effects of mu opioid receptors on dopamine D1 and D2 receptor expressing neurons in opioid mediated antinociception
- 25 June 2025
- Published by Elsevier in The Journal of Pain
- Vol. 35, 105474
Opposing effects of mu opioid receptors on dopamine D1 and D2 receptor expressing neurons in opioid mediated antinociception
- Open Access
- 11 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
The Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians (Preprint)
BACKGROUND Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. OBJECTIVE This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. METHODS The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. RESULTS Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. CONCLUSIONS To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine. CLINICALTRIAL
- 11 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians (Preprint)
BACKGROUND Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. OBJECTIVE This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. METHODS The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. RESULTS Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. CONCLUSIONS To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine. CLINICALTRIAL